Entry |
|
Name |
Efferocytosis - Sclerotinia sclerotiorum |
Class |
Cellular Processes; Transport and catabolism
|
Pathway map |

|
Organism |
Sclerotinia sclerotiorum [GN: ssl]
|
Gene |
|
Compound |
C00019 | S-Adenosyl-L-methionine |
C04230 | 1-Acyl-sn-glycero-3-phosphocholine |
C06124 | Sphingosine 1-phosphate |
C15610 | Cholest-5-ene-3beta,26-diol |
|
Reference |
|
Authors |
Doran AC, Yurdagul A Jr, Tabas I |
Title |
Efferocytosis in health and disease. |
Journal |
|
Reference |
|
Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
Journal |
|
Reference |
|
Authors |
Kawano M, Nagata S |
Title |
Efferocytosis and autoimmune disease. |
Journal |
|
Reference |
|
Authors |
Mehrotra P, Ravichandran KS |
Title |
Drugging the efferocytosis process: concepts and opportunities. |
Journal |
|
Reference |
|
Authors |
Park SY, Kim IS |
Title |
Engulfment signals and the phagocytic machinery for apoptotic cell clearance. |
Journal |
|
Reference |
|
Authors |
Kojima Y, Weissman IL, Leeper NJ |
Title |
The Role of Efferocytosis in Atherosclerosis. |
Journal |
|
Related pathway |
|
KO pathway |
|